Showing 20,121 - 20,140 results of 21,342 for search '(( ((significant decrease) OR (significantly increased)) decrease ) OR ( significant a decrease ))*', query time: 0.91s Refine Results
  1. 20121

    Combined application of <i>Azadirachta indica</i> leaf extract and zerovalent iron nanoparticles (nZVI) enhances phytoremediation potential of <i>Brassica napus</i> L. in surgical... by Mujahid Farid (11619366)

    Published 2025
    “…Plants exposed to untreated wastewater exhibited significant reductions in growth and photosynthetic pigments. …”
  2. 20122

    Highly Sensitive and Selective Electrochemical Sensor via Cu-BTC/Au@Cu-BTC Modified Screen-Printed Electrode for the Detection of Chemical Agents by Xiaosen Li (6263651)

    Published 2025
    “…Chemical agents present significant threat to international peace, security, and human health due to their potential toxicity. …”
  3. 20123

    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  4. 20124

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  5. 20125

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  6. 20126

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  7. 20127

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  8. 20128

    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  9. 20129

    DataSheet1_Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia.pdf by Zsófia Flóra Nagy (19758660)

    Published 2024
    “…Whole exome sequencing revealed a heterozygous missense variant of uncertain significance in the SERPINC1 gene, which has been associated with hereditary antithrombin deficiency. …”
  10. 20130

    Table 4_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  11. 20131

    Table 6_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  12. 20132

    Table 13_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  13. 20133

    Table 10_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  14. 20134

    Table 3_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  15. 20135

    Table 2_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  16. 20136

    Table 11_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  17. 20137

    Table 7_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  18. 20138

    Table 2_Multi-omics identification and validation of oxidative phosphorylation–related hub genes in schizophrenia.docx by Yu Zhou (89766)

    Published 2025
    “…Extending these findings in vivo, MK-801–treated mice exhibited behavioral and neuronal deficits, reduced ATP5A fluorescence intensity, and decreased ATP concentrations; expression of all four hub genes was significantly altered, with three (MALAT1, PPIL3, and ITM2A) concordant with transcriptomic results. …”
  19. 20139

    Table 1_Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease.xlsx by Wenjun Wang (314231)

    Published 2025
    “…The mRNA and protein expression of APRT and LCAT were significantly decreased in COPD patients’ lung tissues.…”
  20. 20140

    Table 1_Multi-omics identification and validation of oxidative phosphorylation–related hub genes in schizophrenia.docx by Yu Zhou (89766)

    Published 2025
    “…Extending these findings in vivo, MK-801–treated mice exhibited behavioral and neuronal deficits, reduced ATP5A fluorescence intensity, and decreased ATP concentrations; expression of all four hub genes was significantly altered, with three (MALAT1, PPIL3, and ITM2A) concordant with transcriptomic results. …”